Deutsche Märkte schließen in 7 Stunden 48 Minuten

Tandem Diabetes Care, Inc. (TNDM)

NasdaqGM - NasdaqGM Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
123,77-1,72 (-1,37%)
Börsenschluss: 4:00PM EDT

Tandem Diabetes Care, Inc.

11075 Roselle Street
San Diego, CA 92121
United States
858 366 6900
http://www.tandemdiabetes.com

Sektor(en)Healthcare
BrancheMedical Devices
Vollzeitmitarbeiter1.500

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. John F. SheridanPres, CEO & Director1,09M7,86M1955
Ms. Leigh A. VossellerExec. VP, CFO & Treasurer618,17k6,97M1973
Ms. Susan M. MorrisonExec. VP & Chief Admin. Officer616,87k6,88M1979
Mr. David B. BergerExec. VP, Chief Bus. Operations & Compliance Officer and Corp. Sec.617,65k4,1M1970
Mr. Brian B. HansenExec. VP & Chief Commercial Officer618,65k10,33M1968
Mr. Jim LealSr. VP of OperationsN/AN/AN/A
Mr. Manuel JaimeSr. VP of Technology & Digital HealthN/AN/AN/A
Mr. Ross SylviaVP of MarketingN/AN/AN/A
Mr. Tom FoxSr. VP of HR & Organizational Devel.N/AN/AN/A
Ms. Elizabeth Anne GasserExec. VP & Chief Strategy OfficerN/AN/A1976
Die Beträge haben den Stand 31. Dezember 2020 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. Its products in development include t:sport insulin delivery system; and connected (mobile) health offerings. Tandem Diabetes Care, Inc. has a development and commercialization agreement with Dexcom, Inc. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Corporate Governance

Tandem Diabetes Care, Inc.s ISS Governance QualityScore, Stand 26. September 2021, lautet 7. Die grundlegenden Scores sind Audit: 10, Vorstand: 5, Shareholderrechte: 6, Kompensation: 6.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.